“Morgellons is delusional parasitosis” is often presented as though it settles the controversy. It does not. It states the prevailing medical interpretation, but it leaves an essential diagnostic question unanswered: what evidence establishes that a particular patient’s observation is false?
LymeX Healthathon Asks Patients What Worked—and What We Can Actually Learn From It
For years, patients with Lyme disease and other complex tick-borne illness histories have argued that some of the most important parts of their medical journeys never make it into a laboratory report. The months spent searching for an explanation can disappear into a sequence of office visits. A symptom pattern that becomes recognizable only in retrospect may be scattered across notes written by several specialists. A treatment that coincided with an unexpected change may be preserved simply as a medication start and stop date, without any meaningful account of what the patient experienced in between.
Morgellons Metagenomic Study: What the DNA Actually Shows
In April 2026, a preprint appeared on bioRxiv with a title that got a lot of people’s attention: Metagenomics reveals a phylogenetically informed microbial signature associated with Morgellons disease. The authors, Andrea Nicole Lambert and William Kindschuh, ran deep metagenomic sequencing on lesion samples and unaffected skin from five members of a single family, all reporting Morgellons symptoms. It is, as far as I can tell, the first time anyone has pointed this particular tool — deep shotgun sequencing of everything genetic in a sample — at Morgellons lesions. In effect, it’s the first Morgellons metagenomic study of its kind.
Beneath the Surface: What Morgellons Histology Shows—and What It Doesn’t
Morgellons disease is usually discussed as a disease of fibers. Under the microscope, however, the more difficult questions concern the skin producing, surrounding, or containing those structures. Published reports describe altered epidermal architecture, abnormal hairs and filaments, comedo-like masses, and thickened follicular casts. None of this proves why Morgellons patients experience stinging, pressure, crawling, or the persistent sensation that something must be removed from the skin. It does raise a question that dermatology has barely studied: what was present at the site before the patient began manipulating it?
Free of Antibiotics, but Not Free of Disease
Long-term antibiotic treatment creates a peculiar milestone in chronic illness communities that receives surprisingly little scientific scrutiny: becoming “antibiotic-free.”
The phrase sounds like recovery. After months or years of prescriptions, an empty medication bottle can seem to mark the end of something difficult and unwanted. Patients remember their last dose, count the months since treatment, and sometimes speak of stopping antibiotics almost as a graduation.
Given the real risks and burdens of prolonged antimicrobial therapy, the desire to reach that point is understandable. Antibiotics can cause adverse effects, alter microbial communities, interact with other medications and, particularly when administered intravenously, expose patients to complications related to vascular access. Nobody should romanticize years of treatment.